Abstract :
[en] The adult hippocampus generates new granule cells (aGCs) with functional capabilities that convey unique forms of plasticity to the preexisting circuits. While early differentiation of adult radial glia-like cells (RGLs) has been studied extensively, the molecular mechanisms guiding the maturation of postmitotic neurons remain unknown. Here, we used a precise birthdating strategy to study aGC differentiation using single-nuclei RNA sequencing. Transcriptional profiling revealed a continuous trajectory from RGLs to mature aGCs, with multiple immature stages bearing increasing levels of effector genes supporting growth, excitability, and synaptogenesis. Analysis of differential gene expression, pseudo-time trajectory, and transcription factors (TFs) revealed critical transitions defining four cellular states: quiescent RGLs, proliferative progenitors, immature aGCs, and mature aGCs. Becoming mature aGCs involved a transcriptional switch that shuts down pathways promoting cell growth, such SoxC TFs, to activate programs that likely control neuronal homeostasis. aGCs overexpressing Sox4 or Sox11 remained immature. Our results unveil precise molecular mechanisms driving adult RGLs through the pathway of neuronal differentiation.
Funding text :
We thank members of the A.F.S., A.C., G. Lanuza, and E. Kropff labs for insightful discussions and M. Trinchero for critical comments on the manuscript. D.G., A.C., and A.F.S. are investigators in the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICE T). N.B.R., A.A.B., and M.S.B. were supported by CONICE T fellowships. P.A. is a SAB member at Foresite Labs, CNSII, and is a cofounder and a SAB member of Vesalius Therapeutics. Funding: This work was supported by NIH grants from the National Institute of Neurological Disorders and Stroke (NINDS), R01NS128117 (P.A.); NINDS and Fogarty International Center, R01NS103758 (A.F.S. and P.A.); and the Argentine Agency for the Promotion of Science and Technology, PICT 2017-0389 (D.G.), PICT 2018-03713 (A.C.), and PICT-2020- 0046 and PICT-2021- 0077 (A.F.S.). Author contributions: Conceptualization: N.B.R., D.G., A.A.B., P.A., A.C., and A.F.S. Software: A.A.B., T.V.W., M.S.B., and A.C. Investigation: N.B.R., D.G., D.J.B.D., J.B., M.G.D.-S., and C.G. Resources: D.C.L. Data curation: A.A.B., T.V.W., M.S.B., and A.C. Visualization: N.B.R., D.G., A.A.B., T.V.W., M.S.B., A.C., and A.F.S. Supervision: P.A., A.C., and A.F.S. Writing-original draft: N.B.R., D.G., A.A.B., M.S.B., A.C., and A.F.S. Writing-review and editing: T.V.W., D.J.D.B., D.C.L., and P.A. Competing interests: P.A. is a SAB member at Foresite Labs, CNSII, and is a cofounder and a SAB member of Vesalius Therapeutics. The authors declare that they have no other competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Datasets 1 and 2 have been deposited in the Gene Expression Omnibus site (accession GSE249796). The computational scripts used in our analysis are available in the Zenodo repository (doi: 10.5281/zenodo.11371903).Acknowledgments: We thank members of the A.F.S., A.c., G. Lanuza, and e. Kropff labs for insightful discussions and M. Trinchero for critical comments on the manuscript. d.G., A.c., and A.F.S. are investigators in the consejo nacional de investigaciones cientificas y Tecnicas (coniceT). n.B.R., A.A.B., and M.S.B. were supported by coniceT fellowships. P.A. is a SAB member at Foresite Labs, cnSii, and is a cofounder and a SAB member of vesalius Therapeutics. Funding: This work was supported by nih grants from the national institute of neurological disorders and Stroke (nindS), R01nS128117 (P.A.); nindS and Fogarty international center, R01nS103758 (A.F.S. and P.A.); and the Argentine Agency for the Promotion of Science and Technology, PicT 2017-0389 (d.G.), PicT 2018-03713 (A.c.), and PicT-2020-0046 and PicT-2021-0077 (A.F.S.). Author contributions: conceptualization: n.B.R., d.G., A.A.B., P.A., A.c., and A.F.S. Software: A.A.B., T.v.W., M.S.B., and A.c. investigation: n.B.R., d.G., d.J.B.d., J.B., M.G.d.-S., and c.G. Resources: d.c.L. data curation: A.A.B., T.v.W., M.S.B., and A.c. visualization: n.B.R., d.G., A.A.B., T.v.W., M.S.B., A.c., and A.F.S. Supervision: P.A., A.c., and A.F.S. Writing\u2014original draft: n.B.R., d.G., A.A.B., M.S.B., A.c., and A.F.S. Writing\u2014review and editing: T.v.W., d.J.d.B., d.c.L., and P.A. Competing interests: P.A. is a SAB member at Foresite Labs, cnSii, and is a cofounder and a SAB member of vesalius Therapeutics. The authors declare that they have no other competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. datasets 1 and 2 have been deposited in the Gene expression omnibus site (accession GSe249796). The computational scripts used in our analysis are available in the Zenodo repository (doi: 10.5281/zenodo.11371903).
Scopus citations®
without self-citations
9